Drawing for ENVARSUS

USPTO serial 79133181

ENVARSUS

Reviewed by CopyMark Law Group

Reg. 4457206Status 707Registered
Filing date
Status date
Registration date
Dec 31, 2013
Examiner
TWOHIG, SHANNON MARIE
Law office
TMO LAW OFFICE 121

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with ENVARSUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Julia Anne Matheson

Julia Anne Matheson Potomac Law Group, PLLC1717 Pennsylvania Avenue, NW, Suite 1025Washington, DC 20006UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, immunotherapeutic and immunosuppressive preparations for medical use for treatment of transplantation patients; medical preparations and drug delivery systems, pharmaceutical modified release systems, and controlled release systems, comprised of tablets, granules, pills, sachets, powders, capsules, all of the above for use in the treatment of mental and physical disorders, traumas and emergencies, addictions, aging, allergy and immunology, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical and gynecological field, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions in the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions and generalised painACTIVE—
040[ Treatment of materials, namely, milling, grinding, mixing, compressing, and melting of pharmaceutical, medicinal, biotechnical and bacteriological substances, preparations, formulations and solutions, for use in the pharmaceutical and medical industries ]SECTION 71 - CANCELLED—
042[ Scientific and technological services, namely, clinical testing and technology transfer services as well as research and design in connection therewith, namely, within the medical, pharmaceutical, biotechnical and bacteriological areas and providing scientific consultation and information relating thereto; conducting of tests regarding medical applications; packaging design for others; designing and development of medical equipment; designing pharmaceutical medical preparations; development of pharmaceutical formulations; design and development of granulation technology and tablet technology and providing consultation and information thereto; materials testing for the pharmaceutical and medical industries ]SECTION 71 - CANCELLED—
044[ Medical services; medical and pharmaceutical assistance and consultation, namely, medical and pharmaceutical information services, namely, providing medical and scientific research information in the field of pharmaceuticals ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 5, 2025INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Jun 20, 2025INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jun 20, 2025INPCINVALIDATION PROCESSED—
Mar 19, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Nov 8, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 19, 2024NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jul 19, 202471.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Jul 19, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 3, 2023ES71TEAS SECTION 71 RECEIVED—
Mar 21, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 21, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 21, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 21, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 21, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 3, 2023RNWLINTERNATIONAL REGISTRATION RENEWED—
Dec 31, 2022REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Sep 18, 2021CHLDCHANGE OF OWNER RECEIVED FROM IB—
May 21, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Apr 16, 2021NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Apr 16, 2021C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Apr 16, 2021PRANPOST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED—
Apr 15, 2021EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Nov 17, 2020PR75POST REGISTRATION ACTION MAILED - SEC. 71 & 15—
Nov 17, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 17, 2020ES75TEAS SECTION 71 & 15 RECEIVED—
Feb 7, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 31, 2018REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Sep 19, 2018CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Aug 3, 2018CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Jan 18, 2018ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jul 21, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 26, 2015ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 20, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 30, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 30, 2014FIMPFINAL DISPOSITION PROCESSED—
Mar 31, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 31, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 15, 2013GPNXNOTIFICATION PROCESSED BY IB—
Oct 15, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 15, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 25, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 25, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 25, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 11, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 11, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 11, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 10, 2013CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Sep 6, 2013CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Sep 5, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 3, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 3, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 29, 2013ALIEASSIGNED TO LIE—
Aug 26, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 26, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 24, 2013RFNTREFUSAL PROCESSED BY IB—
Aug 3, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 2, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 2, 2013RFRRREFUSAL PROCESSED BY MPU—
Aug 2, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 1, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 30, 2013DOCKASSIGNED TO EXAMINER—
Jul 30, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 29, 2013LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jul 25, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance